Staking Our Claim
Reaching New Destinations
Pliant Therapeutics is a clinical-stage biopharmaceutical company and leader in the development of integrin-based therapeutics.
Pliant is diving deep to understand and apply the role of integrins in diseases with the goal of the molecular drivers of diseases to unlock potentially safer and more effective therapies for patients.
Our Team
Pliant is led by a team of world-renowned researchers and highly experienced drug developers focused on translating science into novel therapies for patients in need.
Our Responsibility
While patients are at the center of our corporate responsibility efforts, we recognize that operating in a sustainable manner benefits all of our stakeholders, including employees, investors, environment, communities, and the patients we seek to serve. In that regard, we have undertaken various environmental, social and governance (“ESG”) initiatives, including in the areas of: environmental sustainability; access to our investigational therapies; continuing education and support; charitable contributions; and commitment to compliance and ethical business conduct.
We’re Here for Hope
General Contact
[email protected]
650-481-6770
IR & Media Contact
Christopher Keenan
Pliant Therapeutics
Vice President, Investor Relations and Corporate Communications
[email protected]
HR Contact
331 Oyster Point Blvd
South San Francisco, CA 94080